Entity Type
Company
Filer Snapshot
NEXTBio Capital Management LP
CIK 0002038158. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.
Total Filings
2
Latest Filing
14 May 2026
Industry
n/a
Follow future filing-backed changes
Save this filer to return when a new filing changes the portfolio, large-stake, insider, or company context.
Save and revisit
Save this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Best next click
Start with the summary below, then verify the strongest source-backed page for this filer.
- Open 13F if you want portfolio holdings.
- Open 13D/G or insider pages only when this CIK has those rows.
Source: SEC Form 13F
View Source Filing
13F-HR filed on 14 May 2026 for CIK 0002038158.
- Business address
- 500 W 2 Nd Street, Suite 1900, Austin, TX, 78701
- Top 13F securities
- TERN PTGX STTK VOR CMPS RYTM XENE PVLA ZBIO IVA VSTM CBIO +8 more
- State of incorporation
- DE
- Fiscal year end
- 31 December
Filer intelligence
What SEC filings say about NEXTBio Capital Management LP
A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.
Quick read
- Latest parsed 13F shows $215.37M across 24 reported holdings for Q1 2026.
- Largest parsed 13F holding: TERN at $31.87M.
SEC source mix
Counts show available parsed rows, not one combined ownership total.
Top parsed 13F holdings
Visual share of the latest parsed 13F portfolio. Values are reported market value, not a recommendation.
Top 5 concentration
49%
Share of latest parsed 13F value represented by the visible holdings below.
Top 5 reported value
$105.34M
Compared with $215.37M total 13F value.
Top 5 net change
+$9.83M
Position-value change inside the visible top holdings only.
13F concentration map
A simple visual split of the latest parsed 13F portfolio.
Largest add: CMPS ยท Largest trim: CMPX
TERN
PTGX
STTK
VOR
CMPS
Other holdings
Latest update
What changed recently for NEXTBio Capital Management LP
Latest 13F period: Q1 2026. Open the source-backed page to inspect the fresh filing or facts context.
Update date
14 May 2026
Page type
Filer profile
Latest period
Q1 2026
Institutional portfolio context was refreshed from a 13F filing filed on 14 May 2026.
Benchmark Context
Benchmark context for this company
NEXTBio Capital Management LP has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.
Compared with
Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.
Why this is notable
Latest 13F period: Q1 2026. That gives you a fresh baseline before you compare this company with peers.
- Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
- Open the facts page first if you want the cleanest path to verification.
Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.
SEC filing record
CIK 0002038158 filing coverage
Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.
SEC filings
2
First seen
13 Feb 2026
Latest filing
14 May 2026
Entity
Company
Observed form types
13F-HR
Latest Filings
Recent SEC filings for NEXTBio Capital Management LP with direct links to document and filing folders.
13F-HR
File 028-26345
13F-HR filing
- Filing date
- 14 May 2026
- Reporting date
- 31 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
13F-HR
File 028-26345
13F-HR filing
- Filing date
- 13 Feb 2026
- Reporting date
- 31 Dec 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing